BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...

BTIG analyst Andrew Harte lowered the firm’s price target on Lightspeed (LSPD) to $17 from $21 and keeps a Buy rating on the shares. The shares ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

Dale Asplund; President, Chief Executive Officer, Director; Brightview Holdings Inc. Presentation. For snow businesses in Q2, about 80% plus in Q2. But Q1, we saw ve ...

Paysafe (PSFE) could be valued at $40 a share in a potential acquisition, as the payments firm explores sale options with strategic buyers, according to ...

BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...

HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

BTIG analysts upheld their Buy rating and $15.00 price target for Coya Therapeutics (NASDAQ:COYA), following recent clinical trial data. The stock, currently trading at $7.11, has shown strong ...

Treace provides technology that facilitates Lapiplasty bunion surgery and related midfoot deformities. The company recently ...

The Trump administration will try to return Fannie Mae and Freddie Mac to the private sector, but it probably won’t happen ...

Each Unit Includes One Class A Ordinary Share and One Share Right to Receive 1/15th of a Class A Ordinary Share ...